Results 1 - 20 of 156 in Arena Pharmaceuticals
-
... crisis . Four of the five are expected to at least pace the market's returns. And CAPS members expect Arena Pharmaceuticals will actually outperform the market. Wondering why? So am I. The bull case for Arena Pharmaceuticals ImRichBeotch wrote a ...
Comment?
-
Executive Moves: Irvine Pharmaceutical Services
... 20 years of experience in the pharmaceutical industry having worked at various companies, including Arena Pharmaceuticals, Inc., Magellan Laboratories, Inc., Cabrillo Laboratories, Amylin Pharmaceuticals, Inc., Glaxo research, California ...
Comment?
-
Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems Conference on October 13, 2008 at 8:00 a.m. Eastern Time at the ...
Comment?
-
Why Clean Tech Is Taking Biotech's Shine - BusinessWeek
Nigel Beeley is a biopharma veteran. He spent 25 years in research at such biotechnology companies as Amylin Pharmaceuticals , Arena Pharmaceuticals , and Senomyx .
Comment?
-
Zacks Analyst Blog Highlights: Eli Lilly and Co., Marriott...
Zacks Analyst Blog Highlights: Eli Lilly and Co., Marriott International, Inc., Arena Pharmaceuticals, Inc., ArvinMeritor, Inc.
Comment?
-
Arena Looking Better from Afar
Arena Pharmaceuticals is a biopharmaceutical company with its primary expertise in the area of G protein-coupled receptors .
Comment?
-
FirstAlert: 11-11:40 A.M. Investrend / Bestcalls
... LH), Lennar Corporation (NYSE: LEN), CONMED Corporation (NASDAQ: CNMD), Sealed Air Corp. (NYSE: SEE), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Applied Biosystems Inc. (NYSE: ABI), Cynosure Inc. (NASDAQ: CYNO), National CineMedia Inc. (NASDAQ: ...
Comment?
-
Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Arena Pharmaceuticals Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the UBS Global Life Sciences Conference on September 23, 2008 at 11:00 a.m. Eastern Time at the ...
Comment?
-
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the NewsMakers in the Biotech Industry Conference on September 4, 2008 at ...
Comment?
-
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the NewsMakers in the Biotech Industry Conference on September 4, 2008 at 11:00 a.m. Eastern Time at the Millennium ...
Comment?
-
The Ps and Qs of Getting Products Past FDA Maze
... to understand." Mark Brunswick, a former FDA reviewer and current head of regulatory affairs at Arena Pharmaceuticals Inc., explained that some "FDA speak" is caused by the fact that the agency may be reviewing an application that is similar to ...
Comment?
-
Discovery of the First Potent and Orally Efficacious Agonist of the...
... , § and Robert M. Jones † Departments of Medicinal Chemistry, DMPK, and Discovery Biology, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, California 92121 Received June 5, 2008 Abstract: GPR119 is a rhodopsin-like GPCR ...
Comment?
-
Arena Pharmaceuticals Inc.'s leading pipeline candidate, lorcaserin for obesity, continues is its phase III program.
Comment?
-
Arena Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
Arena Pharmaceuticals Inc. August 5, 2008 5:00 pm ET Executives Jack Lief - CEO Robert Hoffman - CFO Bill Shanahan - VP and Chief Medical Officer Analysts Thomas Wei - Piper Jaffray Bret Holley - Oppenheimer & ...
Comment?
-
Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results ...
SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2008.
Comment?
-
Company and People Notes: West To Reduce Workforce, Eli Lilly's CEO and Chairman To Retire, More
Arena Pharmaceuticals entered into a strategic agreement with Siegfried Ltd., an affiliate of Siegfried Holding AG .
Comment?
-
Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results ...
SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. today announced it will report second quarter 2008 financial results after the NASDAQ Global Market closes on Tuesday, August 5, 2008.
Comment?
-
5 Stocks Approaching Greatness
... to see their patience rewarded? They do if they're long-term investors. It might take that long for Arena Pharmaceuticals to see the benefits of its labor with its obesity drug, lorcaserin, which is currently in phase 3 clinical trials. Although ...
Comment?
-
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial...
Main Category: Cardiovascular / Cardiology Also Included In: Pharma Industry / Biotech Industry Arena Pharmaceuticals, Inc.
Comment?
-
BeaconEquity.com Issues TraderNotes on Active Stocks: SWHC, ARNA, BORL, QTWW, CSGH, FEED, BVN, CEGE
... Today's TraderNotes include: Smith & Wesson Holding Corp. (Nasdaq: SWHC), Arena Pharmaceuticals Inc. (Nasdaq: ARNA ), Borland Software Corp. (Nasdaq: BORL ), Quantum Fuel Systems Technologies Worldwide Inc. (Nasdaq: QTWW), China Sun Group High-Tech ...
Comment?
Arena Pharmaceuticals Forum
Most Popular